GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has ...

You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...

Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.

New research presented May 17 at the American Psychiatric Association's Annual Meeting shows that GLP-1 receptor agonists may ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is not ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Indian drug companies are increasing their presence in the insulin market. They are competing with multinational corporations ...

Divi's posted a 12 per cent growth in revenues over the year-ago quarter. Although revenue growth has moderated after four ...